| Literature DB >> 35650261 |
Leonardo Solaini1,2, Antonio Bocchino3, Andrea Avanzolini4, Domenico Annunziata4, Davide Cavaliere4, Giorgio Ercolani3,4.
Abstract
BACKGROUND: This study aimed to review the new evidence to understand whether the robotic approach could find some clear indication also in left colectomy.Entities:
Keywords: Colorectal surgery; Laparoscopy; Left colectomy; Left hemicolectomy; Robotic surgery
Mesh:
Year: 2022 PMID: 35650261 PMCID: PMC9262793 DOI: 10.1007/s00384-022-04194-8
Source DB: PubMed Journal: Int J Colorectal Dis ISSN: 0179-1958 Impact factor: 2.796
Fig. 1PRISMA flow chart
Study characteristics and quality assessment
| First author | Country | Study period | Study design | Robot | Laparoscopic | Robotic | Q.A | Monocentric |
|---|---|---|---|---|---|---|---|---|
| Lim | Korea | 2006–2008 | Retrospective cohort | Si | 146 | 34 | 8 | Yes |
| Casillas | USA | 2005–2012 | Prospective cohort, PSM | 82 | 68 | 6 | Yes | |
| Cassini | Italy | 2009–2017 | Retrospective cohort | S | 92 | 64 | 8 | Yes |
| Maciel | USA | 2009–2013 | Retrospective cohort | Da Vinci | 55 | 20 | 7 | Yes |
| Bilgin | Turkey | 2011–2018 | Retrospective cohort | Xi | 22 | 20 | 8 | Yes |
| Al Temimi | USA | 2012–2014 | Retrospective cohort, PSM | 439 | 439 | 7 | Database | |
| Kim | Korea | 2012–2017 | Retrospective cohort | Si/Xi | 51 | 20 | 8 | Yes |
| Xu | China | 2012–2018 | Retrospective cohort | Si | 255 | 205 | 8 | Yes |
| Beltzer | Germany | 2013–2018 | Case control retrospective | Xi | 46 | 60 | 8 | Yes |
| Mlambo | USA | 2013–2019 | Retrospective cohort | 37,543 | 12,400 | 8 | Database | |
| Gass | Swiss | 2015–2019 | Retrospective cohort, PSM | Si/Xi | 352 | 176 | 8 | Yes |
QA quality assessment, PSM propensity score matched
Pooled patients' characteristics of robotic versus laparoscopic left colectomies
| Variable | No. Of patients | Robotic | Laparoscopic | References | ||
|---|---|---|---|---|---|---|
| Age (years) | 52,589 | 60.1 (57.2–63.0) | 60.5 (58.2–62.9) | 0.223 | 0.0 (0.0–61.3) | 6–16 |
| Sex, m | 52,589 | 58.6 (43.4–73.1) | 50.9 (45.9–55.8) | 0.289 | 89.2 (82.8–93.3) | 6–16 |
| BMI | 2496 | 26.8 (25.7–27.9 | 26.2 (25.1–27.4) | 1.00 | 0.0 (0.0–0.0) | 6–9, 11–13, 15, 16 |
| ASA > 2 (%) | 2043 | 16.0 (7.9–26.2) | 14.6 (6.8–24.6) | 0.261 | 0.0 (0.0–43.2) | 6, 8, 11–16 |
| Benign disease (%) | 51,878 | 70.4 (44.8–90.6) | 67.4 (36.0–91.9) | 0.228 | 0.0 (0.0–0.0) | 6–10, 12, 14, 16 |
I2 < 25% were interpreted as low heterogeneity, 25 ≤ I2 ≤ 50% as medium, between 50 < I2 ≤ 75% as substantial, I2 > 75% as considerable
Fig. 2Forest plots of a operative time, b blood loss, c stoma, and d conversion to open surgery
Fig. 3Forest plots of a overall complication, b Clavien-Dindo > 2 complications, c mortality, and d hospital stay
Fig. 4Forest plots of a postoperative bleeding, b anastomotic leak, c ileus, and d superficial wound infection
Pooled analyses of robotic versus laparoscopic left colectomies performed for malignancy
| Variable | No. of patients | Robotic | Laparoscopic | References | ||
|---|---|---|---|---|---|---|
| Age (years) | 711 | 60.1 (58.7–61.3) | 59.3 (57.4–61.2) | 0.872 | 0.0 (0.0–81.3) | 11, 13, 15 |
| Sex –m- | 711 | 60.9 (54.9–66.7) | 64.1 (59.6–68.4) | 0.316 | 11.8 (0.0–97.0) | 11, 13, 15 |
| BMI | 711 | 24.8 (24.6–25.2) | 24.2 (23.5–24.9) | 0.203 | 49.4 (0.0–85.3) | 11, 13, 15 |
| ASA > 2 | 711 | 10.7 (7.3–15.1) | 7.4 (5.2–11.0) | 0.324 | 0.0 (0.0–91.6) | 11, 13, 15 |
| Stage III.IV tumors | 711 | 30.4 (24.6–36.5) | 36.3 (32.0–40.8) | 0.156 | 32.7 (0.0–97.6) | 11, 13, 15 |
| Operative time (min) | 711 | 186 (150–222) | 153 (103–203) | 0.002 | 84.2 (52.6–94.7) | 11, 13, 15 |
| Conversion to open surgery | 711 | 0.2 (0.0–1.2) | 0.3 (0.0–1.1) | n.a | 11, 13, 15 | |
| Complications | 711 | 18.0 (6.7–33.2) | 14.4 (7.4–25.4) | 0.477 | 0.0 (0.0–95.1) | 11, 13, 15 |
| Complications Clavien-Dindo ≥ 3 | 711 | 5.5 (3.0–8.9) | 3.6 (0.9–8.1) | 0.997 | 0.0 (0.0–86.2) | 11, 13, 15 |
| Anastomotic leak | 711 | 2.5 (1.0–5.3) | 2.1 (0.8–4.1) | 0.873 | 0.0 (0.0–0.0) | 13, 15 |
| Time to first flatus | 711 | 2.6 (1.5–3.8) | 2.7 (1.8–3.7) | 0.255 | 26.9 (0.0–97.5) | 11, 13, 15 |
| Lymph nodes harvested | 711 | 15.7 (11.7–19.5) | 17.5 (13.3–21.7) | 0.304 | 50.4 (0.0–85.7) | 11, 13, 15 |
| Margin (cm) | 251 | 7.0 (3.5–10.5) | 8.1 (1.7–14.6) | 0.870 | 67.8 (0.0–92.7) | 11, 15 |
| Mortality | 711 | 0.9 (0.1–5.0) | 0.2 (0.0–1.4) | n.a | 11, 13, 15 | |
| Hospital stay (days) | 711 | 6.9 (4.4–9.4) | 7.1 (5.1–9.1) | 0.407 | 69.2 (0.0–91.0) | 11, 13, 15 |
I2 < 25% were interpreted as low heterogeneity, 25 ≤ I2 ≤ 50% as medium, between 50 < I2 ≤ 75% as substantial, I.2 > 75% as considerable. n.a. not available as not enough events